Introduction
Who are the SDA?
The Complete Health Improvement Program (CHIP)
Methods
Study Participants
Factor |
N
| Non-SDA (mean ± SD) |
N
| SDA (mean ± SD) | Test statistic |
p value |
---|---|---|---|---|---|---|
Male | 1881 | 33.3 % | 513 | 33.7 % |
Χ
2(1) = 0.071 | 0.790 |
Age | 5643 | 57.4 ± 12.8 | 1521 | 57.5 ± 13.8 |
t(2276) = −0.387 | 0.699 |
Married | 3493 | 73.7 % | 1121 | 75.5 % |
Χ
2(3) = 5.896 | 0.117 |
Smoker | 133 | 0.6 % | 9 | 2.6 % |
Χ
2(4) = 96.74 | <0.001 |
Weight (lb) | 5132 | 194.7 ± 50.2 | 1365 | 186.3 ± 51.5 |
t(6495) = 5.470 | <0.001 |
BMI (kg/m2) | 5127 | 31.48 ± 7.42 | 1363 | 30.10 ± 7.39 |
t(6488) = 6.103 | <0.001 |
SBP (mm Hg) | 5088 | 133.8 ± 19.1 | 1364 | 132.4 ± 19.3 |
t(6450) = 2.292 | 0.022 |
DBP (mm Hg) | 5084 | 79.91 ± 11.41 | 1366 | 79.28 ± 11.57 |
t(6448) = 1.785 | 0.074 |
TC (mg/dL) | 5218 | 193.2 ± 41.9 | 1400 | 190.4 ± 41.0 |
t(6616) = 2.264 | 0.023 |
LDL (mg/dL) | 5090 | 116.7 ± 35.5 | 1378 | 114.5 ± 35.6 |
t(6466) = 2.245 | 0.041 |
HDL (mg/dL) | 5214 | 49.20 ± 15.28 | 1400 | 48.10 ± 13.55 |
t(2442) = 2.604 | 0.009 |
TC:HDL ratio | 5212 | 4.215 ± 1.372 | 1400 | 4.224 ± 1.400 |
t(6610) = −0.225 | 0.822 |
TG (mg/dL) | 5206 | 142.9 ± 89.0 | 1399 | 143.4 ± 89.7 |
t(6603) = −0.165 | 0.869 |
FPG (mg/dL) | 5181 | 102.9 ± 30.7 | 1381 | 97.78 ± 26.41 |
t(2470) = 6.146 | <0.001 |
Pulse (beats/min) | 4970 | 71.71 ± 11.01 | 1335 | 70.65 ± 10.67 |
t(6303) = 3.147 | 0.002 |
Risk factor | Non-SDA | SDA |
p value4
| ||
---|---|---|---|---|---|
Mean change1 (95 % CI)2
| % change3
| Mean change1 (95 % CI)2
| % change3
| ||
Weight (lb) | −6.489 (−6.669, −6.309)** | −3.3 | −5.862 (−6.185, −5.532)** | −3.1 | 0.001 |
BMI (kg/m2) | −1.039 (−1.067, −1.010)** | −3.3 | −0.933 (−0.984, −0.882)** | −3.1 | <0.001 |
SBP (mm Hg) | −7.158 (−7.539, −6.777)** | −5.3 | −7.988 (−8.671, −7.304)** | −6.0 | 0.038 |
DBP (mm Hg) | −4.216 (−4.475, −3.957)** | −5.3 | −4.144 (−4.607, −3.680)** | −5.2 | 0.790 |
TC (mg/dL) | −21.21 (−21.91, −20.51)** | −11.0 | −18.50 (−19.76, −17.24)** | −9.7 | <0.001 |
LDL (mg/dL) | −15.07 (−15.68, −14.47)** | −12.9 | −13.25 (−14.33, −12.17)** | −11.6 | 0.004 |
HDL (mg/dL) | −4.198 (−4.404, −3.993)** | −8.5 | −3.449 (−3.818, −3.079)** | −7.2 | 0.001 |
TC: HDL ratio | −0.138 (−0.159, −0.116)** | −3.3 | −0.132 (−0.171, −0.093)** | −3.1 | 0.800 |
TG (mg/dL) | −10.89 (−12.40, −9.373)** | −7.6 | −12.76 (−15.47, −10.05)** | −8.9 | 0.238 |
FPG (mg/dL) | −6.366 (−6.779, −5.953)** | −6.2 | −5.580 (−6.324, −4.837)** | −5.7 | 0.071 |
Pulse (beats/min) | −2.558 (−2.816, −2.301)** | −3.6 | −3.129 (−3.590, −2.668)** | −4.4 | 0.035 |
Facilitator Information
Description of CHIP
Data Collection and Reporting
Statistical Analysis
Results
Risk factor | Non-SDA | SDA | ||||
---|---|---|---|---|---|---|
Baseline [N (%)] | 30 days [N (%)]1
| Mean change [(95 % CI) %]2
| Baseline [N (%)] | 30 days [N (%)]1
| Mean change [(95 % CI) %]2
| |
BMI (kg/m2) |
Χ
2 = 561.21, p < 0.001 |
Χ
2 = 148.05, p < 0.001 | ||||
<18.5 | 22 (0.4) | 32 (0.6) | −0.14 (−0.40, 0.12)(0.8) | 15 (1.1) | 14 (1.0) | −0.18 (−0.39, 0.04)(1.0) |
18.5–24.9 | 911 (17.8) | 1154 (22.5) | −0.51 (−0.58, −0.45)**(−2.2) | 326 (23.9) | 397 (29.1) | −0.40 (−0.45, −0.34)**(−1.8) |
25–29.9 | 1534 (29.9) | 1612 (31.4) | −0.89 (−0.92, −0.86)**(−3.2) | 420 (30.8) | 430 (31.5) | −0.80 (−0.86, −0.74)**(−2.9)†
|
≥30 | 2660 (51.9) | 2329 (45.4) | −1.31 (−1.35, −1.27)**(−3.6) | 602 (44.2) | 522 (38.3) | −1.21 (−1.31, −1.12)**(−3.3) |
SBP (mmHg) |
Χ
2 = 763.69, p < 0.001 |
Χ
2 = 234.47, p < 0.001 | ||||
<120 | 1081 (21.2) | 1717 (33.7) | 2.28 (1.59, 2.97)** (2.0) | 327 (24.0) | 519 (38.0) | 1.54 (0.29, 2.78)* (−1.4) |
120–139 | 2213 (43.5) | 2317 (45.5) | −4.56 (−5.07, −4.06)**(−3.5) | 598 (43.8) | 607 (44.5) | −6.06 (−6.99, −5.12)**(−4.7)†
|
140–160 | 1359 (26.7) | 904 (17.8) | −13.45 (−14.19, −12.71)**(−9.1) | 342 (25.1) | 198 (14.5) | −13.88 (−15.31, −12.44)**(−9.4) |
>160 | 435 (8.5) | 150 (2.9) | −25.54 (−27.37, −23.71)**(−14.8) | 97 (7.1) | 40 (2.9) | −23.97 (−28.13, −19.81)**(−13.76) |
DBP (mmHg) |
Χ
2 = 667.59, p < 0.001 |
Χ
2 = 157.44, p < 0.001 | ||||
<80 | 2333 (45.9) | 3184 (62.6) | 0.52 (0.15, 0.90)* (−0.7) | 674 (49.3) | 877 (64.2) | 0.02 (−0.65, 0.69) (−0.0) |
80–89 | 1738 (34.2) | 1471 (28.9) | −6.02 (−6.41, −5.63)**(−7.2) | 451 (33.0) | 380 (27.8) | −5.85 (−6.52, −5.18) **(−7.0) |
90–100 | 882 (17.3) | 398 (7.8) | −10.82 (−11.38, −10.26)**(−11.5) | 208 (15.2) | 93 (6.8) | −10.23 (−11.44, −9.02)**(−10.9) |
>100 | 131 (2.6) | 31 (0.6) | −21.84 (−25.21, −18.47)**(−19.9) | 33 (2.4) | 16 (1.2) | −19.73 (−26.75, −12.71)**(−17.6) |
TC (mg/dL) |
Χ
2 = 1695.09, p < 0.001 |
Χ
2 = 372.62, p < 0.001 | ||||
<160 | 1101 (21.1) | 2071 (39.7) | −7.28 (−8.50, −6.06)**(−5.2) | 320 (22.9) | 533 (38.1) | −4.37 (−6.46, −2.29)**(−3.1) |
160–199 | 1970 (37.8) | 2025 (38.8) | −17.28 (−18.23, −16.33)**(−9.6) | 555 (39.6) | 550 (39.3) | −13.51 (−15.22, −11.80)**(−7.5)††
|
200–239 | 1476 (28.3) | 879 (16.8) | −27.47 (−28.73, −26.21)**(−12.7) | 350 (25.0) | 263 (18.8) | −25.95 (−28.24, −23.67)**(−11.9) |
240–280 | 534 (10.2) | 207 (4.0) | −40.27 (−42.88, −37.65)**(−15.8) | 143 (10.2) | 48 (3.4) | −37.95 (−42.52, −33.37)**(−14.9) |
>280 | 137 (2.6) | 36 (0.7) | −62.13 (−70.63, −53.63)**(−20.0) | 32 (2.3) | 6 (0.4) | −54.48 (−70.18, −38.77)**(−18.1) |
LDL (mg/dL) |
Χ
2 = 1227.51, p < 0.001 |
Χ
2 = 254.93, p < 0.001 | ||||
<100 | 1687 (33.1) | 2525 (49.6) | −5.45 (−6.33, −4.57)**(−6.8) | 517 (37.5) | 698 (50.7) | −2.51 (−3.97, −1.05)*(−3.1)†
|
100–129 | 1695 (33.3) | 1667 (32.8) | −13.35 (−14.29, −12.42)**(−11.7) | 440 (31.9) | 421 (30.6) | −11.75 (−13.38, −10.11)**(−10.3) |
130–159 | 1133 (22.3) | 669 (13.1) | −22.80 (−24.08, −21.51)**(−16.0) | 269 (19.5) | 212 (15.4) | −20.84 (−23.08, −18.60)**(−14.5) |
160–189 | 422 (8.3) | 178 (3.5) | −30.63 (−32.93, −28.34)**(−17.9) | 108 (7.8) | 39 (2.8) | −33.75 (−38.40, −29.09)**(−19.7) |
≥190 | 153 (3.0) | 51 (1.0) | −46.39 (−51.67, −41.10)**(−22.0) | 44 (3.2) | 8 (0.6) | −46.09 (−54.48, −37.70)**(−22.3) |
HDL (mg/dL) |
Χ
2 = 790.25, p < 0.001 |
Χ
2 = 112.15, p < 0.001 | ||||
<40 men, <50 women | 2454 (47.1) | 3213 (61.6) | −1.80 (−2.03, −1.58)**(−4.7) | 685 (48.9) | 846 (60.4) | −1.39 (−1.78, 1.00)**(−3.6) |
40 men/50 women–59 | 1626 (31.2) | 1314 (25.2) | −4.64 (−4.97, −4.31)**(−9.2) | 476 (34.0) | 374 (26.7) | −3.43 (−4.01, −2.85)**(−6.7)†
|
≥60 | 1132 (21.7) | 685 (13.1) | −9.63 (−10.22, −9.05)**(−13.5) | 239 (17.1) | 180 (12.9) | −8.28 (−9.67, −6.90)**(−11.8) |
TG (mg/dL) |
Χ
2 = 105.34, p < 0.001 |
Χ
2 = 49.37, p < 0.001 | ||||
<150 | 3368 (64.7) | 3587 (68.9) | 5.42 (4.24, 6.59)**(−5.7) | 913 (65.3) | 993 (71.0) | 2.63 (0.59, 4.67)* (2.8) |
150–199 | 884 (17.0) | 856 (16.4) | −13.20 (−16.59, −9.82)**(−7.7) | 227 (16.2) | 214 (15.3) | −17.54 (−24.17, −10.91)**(−10.3) |
200–499 | 910 (17.5) | 751 (14.4) | −49.37 (−54.32, −44.42)**(−18.4) | 249 (17.8) | 189 (13.5) | −57.48 (−69.47, −47.48)**(−20.8) |
≥500 | 44 (0.8) | 12 (0.2) | −304.77 (−363.13, −246.42)**(47.5) | 10 (0.7) | 3 (0.2) | −219.91 (−332.72, −107.11)*(−34.2) |
FPG (mg/dL) |
Χ
2 = 445.50, p < 0.001 | Χ2 = 67.56, p < 0.001 | ||||
<100 | 3230 (62.3) | 3769 (72.7) | −1.02 (−1.33, −0.71)** (−1.2) | 974 (70.5) | 1075 (77.8) | −0.27 (−0.94, 0.39) (−0.3) |
100–125 | 1313 (25.3) | 1038 (20.0) | −7.91 (−8.59, −7.24)**(−7.3) | 274 (19.8) | 217 (15.7) | −6.80 (−7.90, −5.71)**(−6.3) |
>125 | 638 (12.3) | 374 (7.2) | −33.06 (−35.89, −30.22)**(−19.9) | 133 (9.6) | 89 (6.4) | −25.34 (−31.26, −19.41)**(−15.8) |